Sample Pretreatment for Confirmation of 19 – Norsteroids by GC – C – IRMS in Doping Control

Sample Pretreatment for Confirmation of 19 – Norsteroids by GC – C – IRMS in Doping Control

ศูนย์ตรวจสอบสารต้องห้ามในนักกีฬา มหาวิทยาลัยมหิดล

ผลงานวิจัย :

Sample Pretreatment for Confirmation of 19 – Norsteroids by GC – C – IRMS in Doping Control

ผู้วิจัย :

Nimsoongnern S., Weewong C., Lohwithee S., Wiriyakosol N., Wilairat P., Kongpatanakul S.

Confirmation of the use of 19-norsteroids requires the identification of the exogenous origin of the main metabolite, 19-norandrosterone (19-NA), when found in the urine at concentrations between 2.5 ng/mL and 15 ng/mL. An effective pretreatment procedure is necessary prior to the IRMS measurement. Two HPLC clean up steps were employed to isolate the fractions of 19-NA, 19-noretiocholanolone (19-NE) and two endogenous reference compounds (ERCs), pregnandiol (PD) and androsterone (Andro). Validation followed the WADA requirements as specified in TD2017NA and TD2016IRMS. Blank urine, 25-30 mL, spiked with 19-NA and 19-NE at 2.5-15 ng/mL, were validated for intra- and inter-assay precisions. The accuracy and fractionation were evaluated using standard 19-NA, 19-NE and certified standard USADA34-1 spiked in stripped urine. The results show no interference peak close to the target compounds. The difference between the 13C (‰) of pure certified standard and spiked stripped urine of less than 0.5 ‰ verified the accuracy of 13C measurement and non-fractionation effect of the sample preparation procedure. This method is fit for the determination of 13C (‰) of 19-NA and 19-NE for anti-doping purposes.

การนำไปใช้ประโยชน์ : ใช้ในห้องปฏิบัติการการวิเคราะห์สารในการกีฬาของศูนย์ ฯ

การเผยแพร่ผลงาน :
Recent Advances in Doping Analysis (25) Proceeding of the Manfred Donike Workshop 35th Cologne Workshop on Dope Analysis. 5th to 10th March 2017, page 136-139.

การติดต่อ :
นางมรกต แก้วกล่ำ
ศูนย์ตรวจสอบสารต้องห้ามในนักกีฬา มหาวิทยาลัยมหิดล
+66 2 354 7149 – 50